Mkts

Fulgent Genetics, Inc.

NASDAQ: FLGT
$24.66-0.19 (-0.76%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
24.3425.00
52-week range
13.4631.04
Today
Open24.85
Previous close24.66
Volume1.10M
Valuation
Market cap697.92M
P/E ratio—
EPS (TTM)-2.83
Income & risk
Dividend / yield—
Beta1.01
Avg volume315.6K
Discussion

FLGT News

Stories mentioning FLGT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue71,13883,33684,06981,80373,46376,21471,74371,028
Cost of Goods Sold49,64850,75448,55747,36845,11744,36544,97244,537
Gross Profit21,49032,58235,51234,43528,34631,84926,77126,491
Operating Expenses
Research & Development14,17614,17013,86013,48012,39512,11311,78313,486
Sales General & Admin
Total Operating Expenses56,11268,82050,86254,14848,14147,98443,85045,397
Operating Income (Loss)(34,622)(36,238)(15,350)(19,713)(19,795)(16,135)(17,079)(18,906)
Interest Income8,6516,9367,8748,0918,0188,1238,0907,706
Interest Expense
Other Expense10.0044.00(5.00)46.0068.0015.00544.0011.00
Pretax Income(25,978)(29,274)(7,509)(21,519)(11,723)(8,037)(18,532)(11,214)
Tax Provision(704.00)(5,624)(683.00)(2,263)176.00(1,847)(3,838)(2,124)
Net Income (Loss)(24,826)(23,418)(6,608)(18,957)(11,530)(5,888)(14,648)(8,710)
Earnings Per Share (Basic)(0.76)(0.19)
Earnings Per Share (Diluted)(0.76)(0.19)
Weighted Average Shares Outstanding (Basic)30,88130,77730,74930,54430,83230,23530,41630,098
Weighted Average Shares Outstanding (Diluted)30,88130,77730,74930,54430,83230,23530,41630,098

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About FLGT

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a stock listed on the Nasdaq Stock Market under the ticker symbol FLGT. It last traded at $24.66 (Nov 13, 2026, 4:00 PM ET), down 0.8% on the day. That gives Fulgent Genetics a market capitalisation of $697.9M.

Over the past 52 weeks FLGT has traded between $13.46 and $31.04.

Revenue for the quarter ended Mar 31, 2026 was $71.1M; a net loss of $24.8M. Revenue was down 3.2% from $73.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$71.1M-$24.8M-34.9%
Dec 31, 2025$83.3M-$23.4M-28.1%
Sep 30, 2025$84.1M-$6.6M-7.9%
Jun 30, 2025$81.8M-$19.0M-23.2%

From Fulgent Genetics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…